Boehringer Ingelheim has turned down its chance to license Nxera Pharma’s phase 2-ready schizophrenia drug candidate, depriving the Japanese drugmaker of a 60 million euro ($70 million) option payment ...

Hold onto your cabbages because Netflix’s live-action “Avatar: The Last Airbender” is back. Netflix has debuted the first trailer for Season 2, which will release on the streamer in 2026. The ...

Netflix dropped a teaser trailer for Avatar: The Last Airbender Season 2, and the Gaang is back! Debuting in 2026, the live-action adaptation of the beloved anime showcases Earthbender, Toph (Miya ...

Netflix confirmed that the live-action series Avatar: The Last Airbender has been renewed for Season 2, which is scheduled to premiere in 2026 The announcement included a first-look poster and key new ...

Before the first season of The Last of Us on HBO had even come to a close, the dread started to build. As one of the many people who played The Last of Us Part 2 back in June 2020, I knew all too well ...

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) released topline data on Wednesday from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with ...

As the family of the last remaining deceased Israeli hostage in Gaza urges a halt to the second phase of US President Trump’s 20-point postwar plan for Gaza, Qatar insists the process must continue.

Betelgeuse, one of the largest stars ever discovered, is reaching the end of its life. In the coming centuries or perhaps even right now it could explode into a supernova visible even during the day.

The biggest stories of the day delivered to your inbox.

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...